FDA warns Chinese providers of compounding APIs over record-request refusals
The FDA has sent warning letters to two Chinese active pharmaceutical ingredient (API) manufacturers that refused to provide records upon…
The FDA has sent warning letters to two Chinese active pharmaceutical ingredient (API) manufacturers that refused to provide records upon…